Medical Tech Company Medtronic Faces Stock Target Cut Amid Business Separation
Medtronic's diabetes business IPO is complete. Analysts adjusted price targets, while a new AI-assisted surgical system received FDA clearance. Another company acquired a rare disease drugmaker.